Click for best price
Biological Drugs Market Size, Share 2022
Market Analysis and Insights: Global Biological Drugs Market
The global Biological Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biological Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biological Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biological Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biological Drugs market.
Global Biological Drugs Scope and Market Size
Biological Drugs market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Biological Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Biological Drugs market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Therapeutic Protein
Monoclonal Antibody
Vaccine
Others
Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Bristol-Myers Squibb
Eli Lilly
Takeda
Pfizer
Amgen
F. Hoffmann-La Roche
Johnson & Johnson
Merck
Abbott Laboratories
Baxter
Novartis
Biogen
GlaxoSmithKline
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Biological Drugs product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Biological Drugs, with price, sales, revenue, and global market share of Biological Drugs from 2019 to 2022.
Chapter 3, the Biological Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biological Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Biological Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biological Drugs.
Chapter 13, 14, and 15, to describe Biological Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Biological Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global and United States Biological Drugs Market Report & Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
102 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Biological Drugs Product Introduction
1.2 Global Biological Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Biological Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Biological Drugs Sales in Volume for the Year 2017-2028
1.3 United States Biological Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Biological Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Biological Drugs Sales in Volume for the Year 2017-2028
1.4 Biological Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Biological Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Biological Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Biological Drugs Market Dynamics
1.5.1 Biological Drugs Industry Trends
1.5.2 Biological Drugs Market Drivers
1.5.3 Biological Drugs Market Challenges
1.5.4 Biological Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Biological Drugs Market Segment by Type
2.1.1 Therapeutic Protein
2.1.2 Monoclonal Antibody
2.1.3 Vaccine
2.1.4 Others
2.2 Global Biological Drugs Market Size by Type
2.2.1 Global Biological Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Biological Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Biological Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Biological Drugs Market Size by Type
2.3.1 United States Biological Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Biological Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Biological Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Biological Drugs Market Segment by Application
3.1.1 Hospitals
3.1.2 Ambulatory Surgical Centers
3.1.3 Others
3.2 Global Biological Drugs Market Size by Application
3.2.1 Global Biological Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Biological Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Biological Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Biological Drugs Market Size by Application
3.3.1 United States Biological Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Biological Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Biological Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Biological Drugs Competitor Landscape by Company
4.1 Global Biological Drugs Market Size by Company
4.1.1 Top Global Biological Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Biological Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Biological Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Biological Drugs Price by Manufacturer (2017-2022)
4.2 Global Biological Drugs Concentration Ratio (CR)
4.2.1 Biological Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Biological Drugs in 2021
4.2.3 Global Biological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Biological Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Biological Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Biological Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Biological Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Biological Drugs Market Size by Company
4.5.1 Top Biological Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Biological Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Biological Drugs Sales by Players (2020, 2021 & 2022)
5 Global Biological Drugs Market Size by Region
5.1 Global Biological Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Biological Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Biological Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Biological Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Biological Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Biological Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Biological Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Biological Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Biological Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Biological Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Biological Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Biological Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Biological Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Biological Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Biological Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Biological Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Biological Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Bristol-Myers Squibb
7.1.1 Bristol-Myers Squibb Corporation Information
7.1.2 Bristol-Myers Squibb Description and Business Overview
7.1.3 Bristol-Myers Squibb Biological Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Bristol-Myers Squibb Biological Drugs Products Offered
7.1.5 Bristol-Myers Squibb Recent Development
7.2 Eli Lilly
7.2.1 Eli Lilly Corporation Information
7.2.2 Eli Lilly Description and Business Overview
7.2.3 Eli Lilly Biological Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Eli Lilly Biological Drugs Products Offered
7.2.5 Eli Lilly Recent Development
7.3 Takeda
7.3.1 Takeda Corporation Information
7.3.2 Takeda Description and Business Overview
7.3.3 Takeda Biological Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Takeda Biological Drugs Products Offered
7.3.5 Takeda Recent Development
7.4 Pfizer
7.4.1 Pfizer Corporation Information
7.4.2 Pfizer Description and Business Overview
7.4.3 Pfizer Biological Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Pfizer Biological Drugs Products Offered
7.4.5 Pfizer Recent Development
7.5 Amgen
7.5.1 Amgen Corporation Information
7.5.2 Amgen Description and Business Overview
7.5.3 Amgen Biological Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Amgen Biological Drugs Products Offered
7.5.5 Amgen Recent Development
7.6 F. Hoffmann-La Roche
7.6.1 F. Hoffmann-La Roche Corporation Information
7.6.2 F. Hoffmann-La Roche Description and Business Overview
7.6.3 F. Hoffmann-La Roche Biological Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 F. Hoffmann-La Roche Biological Drugs Products Offered
7.6.5 F. Hoffmann-La Roche Recent Development
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Corporation Information
7.7.2 Johnson & Johnson Description and Business Overview
7.7.3 Johnson & Johnson Biological Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Johnson & Johnson Biological Drugs Products Offered
7.7.5 Johnson & Johnson Recent Development
7.8 Merck
7.8.1 Merck Corporation Information
7.8.2 Merck Description and Business Overview
7.8.3 Merck Biological Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Merck Biological Drugs Products Offered
7.8.5 Merck Recent Development
7.9 Abbott Laboratories
7.9.1 Abbott Laboratories Corporation Information
7.9.2 Abbott Laboratories Description and Business Overview
7.9.3 Abbott Laboratories Biological Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Abbott Laboratories Biological Drugs Products Offered
7.9.5 Abbott Laboratories Recent Development
7.10 Baxter
7.10.1 Baxter Corporation Information
7.10.2 Baxter Description and Business Overview
7.10.3 Baxter Biological Drugs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Baxter Biological Drugs Products Offered
7.10.5 Baxter Recent Development
7.11 Novartis
7.11.1 Novartis Corporation Information
7.11.2 Novartis Description and Business Overview
7.11.3 Novartis Biological Drugs Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Novartis Biological Drugs Products Offered
7.11.5 Novartis Recent Development
7.12 Biogen
7.12.1 Biogen Corporation Information
7.12.2 Biogen Description and Business Overview
7.12.3 Biogen Biological Drugs Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Biogen Products Offered
7.12.5 Biogen Recent Development
7.13 GlaxoSmithKline
7.13.1 GlaxoSmithKline Corporation Information
7.13.2 GlaxoSmithKline Description and Business Overview
7.13.3 GlaxoSmithKline Biological Drugs Sales, Revenue and Gross Margin (2017-2022)
7.13.4 GlaxoSmithKline Products Offered
7.13.5 GlaxoSmithKline Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Biological Drugs Industry Chain Analysis
8.2 Biological Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Biological Drugs Distributors
8.3 Biological Drugs Production Mode & Process
8.4 Biological Drugs Sales and Marketing
8.4.1 Biological Drugs Sales Channels
8.4.2 Biological Drugs Distributors
8.5 Biological Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Biological Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Biological Drugs Market Trends
Table 3. Biological Drugs Market Drivers
Table 4. Biological Drugs Market Challenges
Table 5. Biological Drugs Market Restraints
Table 6. Global Biological Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Biological Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Biological Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Biological Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Biological Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Biological Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Biological Drugs Revenue Share by Manufacturer, 2017-2022
Table 13. Global Biological Drugs Sales by Manufacturer, (K MT), 2017-2022
Table 14. Global Biological Drugs Sales Share by Manufacturer, 2017-2022
Table 15. Global Biological Drugs Price by Manufacturer (2017-2022) & (USD/MT)
Table 16. Global Biological Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Biological Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biological Drugs as of 2021)
Table 18. Top Players of Biological Drugs in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Biological Drugs Product Type
Table 20. Date of International Manufacturers Enter into Biological Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Biological Drugs Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Biological Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Biological Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Biological Drugs Sales by Players, (K MT), 2020, 2021 & 2022
Table 26. United States Biological Drugs Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Biological Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Biological Drugs Sales in Volume by Region (2017-2022) & (K MT)
Table 29. Global Biological Drugs Sales in Volume Forecast by Region (2023-2028) & (K MT)
Table 30. Global Biological Drugs Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Biological Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Biological Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 33. North America Biological Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Biological Drugs Sales in Volume by Region (2017-2028) & (K MT)
Table 35. Asia Pacific Biological Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Biological Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 37. Europe Biological Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Biological Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 39. Latin Americaa Biological Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Biological Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 41. Middle East and Africa Biological Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Bristol-Myers Squibb Corporation Information
Table 43. Bristol-Myers Squibb Description and Business Overview
Table 44. Bristol-Myers Squibb Biological Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 45. Bristol-Myers Squibb Biological Drugs Product
Table 46. Bristol-Myers Squibb Recent Development
Table 47. Eli Lilly Corporation Information
Table 48. Eli Lilly Description and Business Overview
Table 49. Eli Lilly Biological Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 50. Eli Lilly Product
Table 51. Eli Lilly Recent Development
Table 52. Takeda Corporation Information
Table 53. Takeda Description and Business Overview
Table 54. Takeda Biological Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 55. Takeda Product
Table 56. Takeda Recent Development
Table 57. Pfizer Corporation Information
Table 58. Pfizer Description and Business Overview
Table 59. Pfizer Biological Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 60. Pfizer Product
Table 61. Pfizer Recent Development
Table 62. Amgen Corporation Information
Table 63. Amgen Description and Business Overview
Table 64. Amgen Biological Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 65. Amgen Product
Table 66. Amgen Recent Development
Table 67. F. Hoffmann-La Roche Corporation Information
Table 68. F. Hoffmann-La Roche Description and Business Overview
Table 69. F. Hoffmann-La Roche Biological Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 70. F. Hoffmann-La Roche Product
Table 71. F. Hoffmann-La Roche Recent Development
Table 72. Johnson & Johnson Corporation Information
Table 73. Johnson & Johnson Description and Business Overview
Table 74. Johnson & Johnson Biological Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 75. Johnson & Johnson Product
Table 76. Johnson & Johnson Recent Development
Table 77. Merck Corporation Information
Table 78. Merck Description and Business Overview
Table 79. Merck Biological Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 80. Merck Product
Table 81. Merck Recent Development
Table 82. Abbott Laboratories Corporation Information
Table 83. Abbott Laboratories Description and Business Overview
Table 84. Abbott Laboratories Biological Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 85. Abbott Laboratories Product
Table 86. Abbott Laboratories Recent Development
Table 87. Baxter Corporation Information
Table 88. Baxter Description and Business Overview
Table 89. Baxter Biological Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 90. Baxter Product
Table 91. Baxter Recent Development
Table 92. Novartis Corporation Information
Table 93. Novartis Description and Business Overview
Table 94. Novartis Biological Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 95. Novartis Product
Table 96. Novartis Recent Development
Table 97. Biogen Corporation Information
Table 98. Biogen Description and Business Overview
Table 99. Biogen Biological Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 100. Biogen Product
Table 101. Biogen Recent Development
Table 102. GlaxoSmithKline Corporation Information
Table 103. GlaxoSmithKline Description and Business Overview
Table 104. GlaxoSmithKline Biological Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 105. GlaxoSmithKline Product
Table 106. GlaxoSmithKline Recent Development
Table 107. Key Raw Materials Lists
Table 108. Raw Materials Key Suppliers Lists
Table 109. Biological Drugs Customers List
Table 110. Biological Drugs Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Biological Drugs Product Picture
Figure 2. Global Biological Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Biological Drugs Market Size 2017-2028 (US$ Million)
Figure 4. Global Biological Drugs Sales 2017-2028 (K MT)
Figure 5. United States Biological Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Biological Drugs Market Size 2017-2028 (US$ Million)
Figure 7. United States Biological Drugs Sales 2017-2028 (K MT)
Figure 8. United States Biological Drugs Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Biological Drugs Market Share in Global, in Volume (K MT) 2017-2028
Figure 10. Biological Drugs Report Years Considered
Figure 11. Product Picture of Therapeutic Protein
Figure 12. Product Picture of Monoclonal Antibody
Figure 13. Product Picture of Vaccine
Figure 14. Product Picture of Others
Figure 15. Global Biological Drugs Market Share by Type in 2022 & 2028
Figure 16. Global Biological Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 17. Global Biological Drugs Sales Market Share in Value by Type (2017-2028)
Figure 18. Global Biological Drugs Sales by Type (2017-2028) & (K MT)
Figure 19. Global Biological Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 20. Global Biological Drugs Price by Type (2017-2028) & (USD/MT)
Figure 21. United States Biological Drugs Market Share by Type in 2022 & 2028
Figure 22. United States Biological Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 23. United States Biological Drugs Sales Market Share in Value by Type (2017-2028)
Figure 24. United States Biological Drugs Sales by Type (2017-2028) & (K MT)
Figure 25. United States Biological Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 26. United States Biological Drugs Price by Type (2017-2028) & (USD/MT)
Figure 27. Product Picture of Hospitals
Figure 28. Product Picture of Ambulatory Surgical Centers
Figure 29. Product Picture of Others
Figure 30. Global Biological Drugs Market Share by Application in 2022 & 2028
Figure 31. Global Biological Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 32. Global Biological Drugs Sales Market Share in Value by Application (2017-2028)
Figure 33. Global Biological Drugs Sales by Application (2017-2028) & (K MT)
Figure 34. Global Biological Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 35. Global Biological Drugs Price by Application (2017-2028) & (USD/MT)
Figure 36. United States Biological Drugs Market Share by Application in 2022 & 2028
Figure 37. United States Biological Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 38. United States Biological Drugs Sales Market Share in Value by Application (2017-2028)
Figure 39. United States Biological Drugs Sales by Application (2017-2028) & (K MT)
Figure 40. United States Biological Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 41. United States Biological Drugs Price by Application (2017-2028) & (USD/MT)
Figure 42. North America Biological Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 43. North America Biological Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 44. U.S. Biological Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Canada Biological Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. Europe Biological Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 47. Europe Biological Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 48. Germany Biological Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. France Biological Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. U.K. Biological Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Italy Biological Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Russia Biological Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Asia-Pacific Biological Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 54. Asia-Pacific Biological Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 55. China Biological Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Japan Biological Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. South Korea Biological Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. India Biological Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Australia Biological Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Taiwan Biological Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Indonesia Biological Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Thailand Biological Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Malaysia Biological Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Philippines Biological Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Latin America Biological Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 66. Latin America Biological Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 67. Mexico Biological Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Brazil Biological Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Argentina Biological Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Middle East & Africa Biological Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 71. Middle East & Africa Biological Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 72. Turkey Biological Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Saudi Arabia Biological Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. U.A.E Biological Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. Biological Drugs Value Chain
Figure 76. Biological Drugs Production Process
Figure 77. Channels of Distribution
Figure 78. Distributors Profiles
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
